CFA
MIST icon

Carroll Financial Associates’s Milestone Pharmaceuticals MIST Stock Holding History

Carroll Financial Associates’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
40
– – ﹤0.01% 1813
2021
Q3 		$0 Hold
40
– – ﹤0.01% 1874
2021
Q2 		$0 Hold
40
– – ﹤0.01% 1783
2021
Q1 		$0 Hold
40
– – ﹤0.01% 1703
2020
Q4 		$0 Hold
40
– – ﹤0.01% 1599
2020
Q3 		$0 Hold
40
– – ﹤0.01% 1599
2020
Q2 		$0 Buy
+40
New +$129 ﹤0.01% 1616

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carroll Financial Associates's MIST Position: Q4 2021 in Review

Carroll Financial Associates held its Milestone Pharmaceuticals (MIST) position steady in Q4 2021 at 40 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Carroll Financial Associates first reported a position in MIST in Q2 2020 and has held it in 7 quarters since. 28 funds tracked by Wall St. Rank hold MIST as of Q4 2021.

  • Carroll Financial Associates held 40 shares of Milestone Pharmaceuticals worth $0 as of Q4 2021.
  • Carroll Financial Associates left its Milestone Pharmaceuticals share count unchanged in Q4 2021.
  • Milestone Pharmaceuticals made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1813 holding.
  • Carroll Financial Associates first reported a position in Milestone Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
  • 28 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.